DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.87	15.65	3.03	4.54	4.73	4.71
Short-Term Investments	46.46	44.24	41.12	48.35	28.77	40.41
Cash & Short-Term Investments	51.33	59.89	44.15	52.9	33.5	45.11
Cash Growth	41.33%	35.66%	-16.54%	57.89%	-25.74%	64.00%
Accounts Receivable	0.3	0.26	0.24	0.37	0.08	0.13
Other Current Assets	0.73	0.48	0.23	0.41	0.25	0.2
Total Current Assets	52.36	60.63	44.61	53.68	33.84	45.44
Net Property, Plant & Equipment	0.32	0.34	0.43	0.49	0.56	0.11
Other Long-Term Assets	0.4	0.4	1.31	-	-	-
Total Assets	53.08	61.37	46.35	54.16	34.4	45.55
Accounts Payable	3.29	1.48	0.94	0.93	0.73	0.51
Accrued Expenses	2.34	3.55	4.35	1.78	1.37	0.97
Current Portion of Leases	0.12	0.11	0.1	0.08	0.07	0.05
Total Current Liabilities	5.75	5.13	5.39	2.79	2.17	1.52
Long-Term Leases	0.1	0.13	0.24	0.32	0.4	0
Total Long-Term Liabilities	0.1	0.13	0.24	0.32	0.4	0
Total Liabilities	5.85	5.26	5.63	3.1	2.57	1.53
Additional Paid-in Capital	230.07	228.83	180.7	166.61	128.08	126.58
Accumulated Other Comprehensive Income	-0.03	0.05	0.02	0.01	-0.07	-0.05
Retained Earnings	-	-172.77	-140	-115.56	-96.18	-82.5
Shareholders' Equity	47.24	56.11	40.72	51.06	31.83	44.02
Total Liabilities & Equity	53.08	61.37	46.35	54.16	34.4	45.55
Total Debt	0.21	0.24	0.34	0.4	0.47	0.05
Net Cash (Debt)	51.12	59.65	43.81	52.5	33.03	45.06
Net Cash Growth	-14.30%	36.17%	-16.55%	58.92%	-26.69%	64.52%
Net Cash Per Share	1.03	1.27	1.08	1.61	1.25	2.17
Book Value	47.24	56.11	40.72	51.06	31.83	44.02
Book Value Per Share	0.95	1.19	1.01	1.57	1.20	2.12
Tangible Book Value	47.24	56.11	40.72	51.06	31.83	44.02
Tangible Book Value Per Share	0.95	1.19	1.01	1.57	1.20	2.12

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q